ROYAL BANK OF CANADA - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 150 filers reported holding FATE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,000
-38.8%
14,356
+36.8%
0.00%
Q2 2023$49,000
+19.5%
10,493
+47.6%
0.00%
Q1 2023$41,000
-82.5%
7,111
-69.3%
0.00%
Q4 2022$234,000
+127.2%
23,132
+405.6%
0.00%
Q3 2022$103,000
+3.0%
4,575
+13.8%
0.00%
Q2 2022$100,000
-76.9%
4,019
-64.0%
0.00%
Q1 2022$433,000
-72.5%
11,176
-58.5%
0.00%
Q4 2021$1,577,000
+149.1%
26,948
+152.6%
0.00%
Q3 2021$633,000
-95.2%
10,670
-92.9%
0.00%
-100.0%
Q2 2021$13,060,000
+362.0%
150,488
+338.7%
0.00%
+200.0%
Q1 2021$2,827,000
+15605.6%
34,303
+17224.7%
0.00%
Q4 2020$18,000
-48.6%
198
-77.4%
0.00%
Q3 2020$35,000
+118.8%
877
+90.2%
0.00%
Q2 2020$16,000
+166.7%
461
+64.1%
0.00%
Q1 2020$6,000
-85.7%
281
-87.0%
0.00%
Q4 2019$42,0002,163
+35950.0%
0.00%
Q2 2019$0
-100.0%
6
-99.6%
0.00%
Q3 2018$24,000
+2300.0%
1,451
+1365.7%
0.00%
Q2 2018$1,00099
+41.4%
0.00%
Q4 2017$0
-100.0%
70
-98.0%
0.00%
Q3 2017$14,0003,425
+56983.3%
0.00%
Q1 2017$0
-100.0%
6
-94.2%
0.00%
Q3 2015$1,000
-66.7%
103
-74.4%
0.00%
Q2 2015$3,0004030.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders